Daratumumab activity in relapsed or primary refractory systemic AL amyloidosis and Fcγ receptor 3A V158F polymorphisms
Xingguang Lee, Lisa, Zhou, Ping, Varga, Cindy, Fogaren, Teresa, Ho, Katelynn, Ma, Xun, Warner, Melissa, Toskic, Denis, Kugelmass, Adin, Comenzo, Raymond L.Journal:
Amyloid
DOI:
10.1080/13506129.2019.1600498
Date:
May, 2019
File:
PDF, 671 KB
2019